Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 12 December 2026
- Last conf. stmt
- 28 November 2025
Cellinta Ltd
- Incorporated
- 16 August 2019 (7 years)
- Previously known as
- Biotech 2 Ltd (until 25 February 2020)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- Accounts type
- Micro entity
- Region
- Greater London
- Address
- 71 KingswayLondonWC2B 6ST
Charges
- Total
- 2
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 2
Officers
Not loaded yet. See them on Companies House
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 10 July 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Liability Partnership
Reg. no. Oc425672
Former controllers (4)
19 November 2020
Ceased Steve Pollard — Owns 25–50% of shares
10 July 2020
Ceased Steven Michael Pollard — Owns 75–100% of shares
10 July 2020
Ceased SV7 (Imf) GP LLP — Owns 75–100% of shares
12 December 2019
Ceased Dementia Discovery GP LP — Owns 75–100% of shares
Group structure 21 shown
Ownership group derived from the Companies House PSC register
DDF 2 FP GP LLP Holds 25–50% of voting rights
DDF 2 FP LP Has significant influence or control
DDF 2 GP LLP Holds 25–50% of voting rights
SV Bco I FP GP LLP Holds 25–50% of voting rights
SV Bco I FP LP Right to appoint and remove a person
SV Bco I GP LLP Holds 25–50% of voting rights
Serenza Therapeutics Ltd Owns 25–50% of shares
SV Health Managers LLP Holds 75–100% of voting rights
Dementia Discovery GP LP Has significant influence or control
Harness Therapeutics Limited Holds 75–100% of voting rights
Loqus23 Therapeutics Limited Owns 25–50% of shares
SV DDF Number 1 Limited Owns 75–100% of shares
Dementia Discovery General Partner LLP Holds 75–100% of voting rights
SV DDF Number 2 Limited Owns 75–100% of shares
SV7 (Imf) FP LP Has significant influence or control
SV7 (Imf) FP GP LLP Holds 25–50% of voting rights
SV7 (Imf) GP LLP Holds 25–50% of voting rights
Cellinta Ltd This company Owns 75–100% of shares
SV8 Bio FP GP LLP Holds 25–50% of voting rights
SV8 Biotech FP LP Part right to 75–100% of surplus assets
Financials
Balance sheet as at 31 December 2025 · micro entity accounts
- Net Assets
- £0
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Fixed Assets | £0 | |||
| Current Assets | £0 | £9,605 | £10,042 | |
| Debtors | £2,601 | |||
| Cash | £7,441 | |||
| Creditors (< 1 year) | £0 | £0 | £4,377 | £0 |
| Creditors (> 1 year) | £0 | |||
| Net Current Assets | £0 | £0 | £5,228 | £10,042 |
| Net Assets | £0 | £0 | £5,228 | £10,042 |
| Shareholder Funds | £0 | £0 | £5,228 | £10,042 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 2 April 2026 | Micro company accounts | 31 December 2025 | ||
| 12 December 2025 | Confirmation statement with no updates | 28 November 2025 | ||
| 6 June 2025 | Micro company accounts | 31 December 2024 | ||
| 9 December 2024 | Confirmation statement with no updates | 28 November 2024 | ||
| 13 May 2024 | Micro company accounts | 31 December 2023 |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →